- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02487420
Gradual Egg-tolerance Induction in Hen's Egg Allergic Children (TETI)
Trapsgewijze Ei-tolerantie-inductie Bij Kippenei-allergische Kinderen (TETI Studie)
- The investigators here want to test the hypothesis that a total period of 18 months of gradual open introduction of a certain egg product with regard to full egg tolerance induction is not inferior when compared to a total period of 30 months gradual open introduction of a certain egg product (see steps for the specific egg products) after tolerance for baked egg has been obtained.
- The investigators also want to define step-specific 'tolerance-failures' and study the relevance of specific IgE to specific egg components to predict failures at each step.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- The investigators here want to test the hypothesis that a total period of 18 months of gradual open introduction of a certain egg product with regard to full egg tolerance induction is not inferior when compared to a total period of 30 months gradual open introduction of a certain egg product (see steps for the specific egg products) after tolerance to baked egg has been obtained.
- The investigators also want to define step-specific 'tolerance-failures' and study the relevance of specific IgE to specific egg components to predict failures at each step.
Step 1: open baked egg test passed (either at home or in the hospital): this is routine clinical practice; afterwards daily intake of increasing amounts of heated egg (amounts to be noted in diary)
Step 2: open provocation test at home with hard-boiled egg, both hen's egg white and yolk, passed; afterwards weekly intake of either hard-boiled egg white or yolk or both (amounts and days to be noted in diary)
Step 3: open provocation test at home with waffles, omelet, pan cake or scrambled egg passed; afterwards weekly or two-weekly intake of one of these specific preparation forms or of the previous preparation forms (amounts, days and preparation to be noted in diary)
Step 4: open provocation test at home with fried or poached egg or softly boiled egg with liquid yolk; afterwards regular intake of one of these preparation forms or one of the prior steps (amounts, days and preparation to be noted in diary)
Step 5: open provocation test at home with raw egg: eg. In chocolate mousse; mayonnaise or tiramisu; afterwards unlimited intake of all egg containing preparation forms (for 3 months in both groups to be noted in the diary)
If tolerance to a certain step is not yet present (this is: if any reaction occurred during the months registered between two steps), the next step will be postponed. The number of failures (any reaction in relation to egg ingestion), the type of reaction and the additional time period necessary before the next step can be taken, will be recorded. After each time period, the investigators will measure specific IgE to hen's egg white and to Gal d 1, as standard clinical practice.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bonheiden, Belgium
- Imelda Hospital, Bonheiden
-
Brugge, Belgium, 8000
- Sint-Jan
-
Ghent, Belgium
- Algemeen Ziekenhuis Maria Middelares
-
Hasselt, Belgium
- Jessa hospital
-
Oostende, Belgium, 8400
- Sint-Jan
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgium, 3000
- University Hospital of Leuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children (1-18y) had or have a clinical diagnosis of IgE mediated hen's egg allergy based on positive history as well as skin prick testing and/or specific IgE detection by CAPtest in an allergy clinic
- Children are at least 12 months old before introduction of heated egg is considered
- Children did not suffer from a moderate-to-severe anaphylaxis due to egg-ingestion at presentation
- Children have specific IgE levels to Gal d 1 below 1.2 kU/mL or passed cake provocation test -
Exclusion Criteria:
- Children had a moderate-to severe anaphylaxis due to egg ingestion
- Children are younger than 12 months old at the moment of passing heated egg open provocation test
- Parents are not able or not willing to test a certain step in the tolerance induction at home -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Arm 18m
arm 18m: 6 months between step 1 and step 2; 6 months between step 2 and step 3, 3 months between all other steps step by step gradual introduction of egg containing food products during 18 months, unless next step can not be taken
|
step by step gradual introduction of egg containing food products
|
Other: arm 30 m
arm 30m: 9 months between step 1 and step 2; 9 months between step 2 and step 3, 6 months between all other steps step by step gradual introduction of egg containing food products during 30 months, unless next step can not be taken
|
step by step gradual introduction of egg containing food products
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
time to complete egg tolerance
Time Frame: 18 to 30 months
|
raw egg tolerance (eg in chocolate mousse)
|
18 to 30 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Measurement of specific IgE to egg white components to predict complete egg tolerance
Time Frame: 18 to 30 months
|
18 to 30 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dominique MA Bullens, MD, PhD, UZ Leuven
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S57588
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Egg Hypersensitivity
-
Aimmune Therapeutics, Inc.TerminatedHen Egg AllergyUnited States
-
Ospedale Buon Consiglio FatebenefratelliCompleted- Egg HypersensitivityItaly
-
University of North Carolina, Chapel HillUniversity of ArkansasCompletedFood HypersensitivityUnited States
-
Turku University HospitalUnknownEgg Allergy | Cow's Milk Allergy
-
Tampere University HospitalOulu University Hospital; University of OuluRecruiting
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedEgg Allergy | Hypersensitivity | Eczema | Food AllergyUnited Kingdom
-
Universitair Ziekenhuis BrusselCompletedHypersensitivity | Allergy, Egg | Soy AllergyBelgium
-
Helsinki University Central HospitalCompleted
-
National Jewish HealthCompletedEgg Allergy | Peanut Allergy | Milk AllergyUnited States
-
Murdoch Childrens Research InstituteRecruitingFood Allergy | Food Allergy in InfantsAustralia
Clinical Trials on shorter or longer period of specific dietary restrictions
-
Dominque BullensImelda Hospital, Bonheiden; AZ Sint-Jan AVActive, not recruitingEgg HypersensitivityBelgium
-
Tufts Medical CenterNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Lidian ChenPeking University Third HospitalNot yet recruiting
-
NYU Langone HealthCompletedMyocardial Infarction | Cardiovascular Diseases | Atherosclerotic Cardiovascular Disease | Thrombotic Vascular DiseaseUnited States
-
Alfa Wassermann TunisiaPoseidon CROUnknownPeripheral Arterial Obstructive DiseaseTunisia